Organigram And This Canadian Cannabis Brand Expand In Europe And Beyond
Portfolio Pulse from Jelena Martinovic
Organigram Holdings Inc. (NASDAQ:OGI) announced a partnership with Avida Medical to supply 1,700 kilograms of medical cannabis in the UK over three years. This move is part of Organigram's broader strategy to expand into the European market. Additionally, Canadian cannabis brand Ghost Drops has partnered with SOMAÍ Group to distribute its products across Europe, the UK, and Australia.
May 28, 2024 | 2:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Organigram Holdings Inc. (NASDAQ:OGI) has partnered with Avida Medical to supply 1,700 kilograms of medical cannabis in the UK over three years. This expansion into the UK market is expected to boost Organigram's revenue and market presence in Europe.
The partnership with Avida Medical signifies a strategic move for Organigram to tap into the growing UK medical cannabis market. The expected supply of 1,700 kilograms over three years should positively impact the company's revenue and market presence in Europe.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100